Table 1.
Demographic Data of the participants.
| Group | ALSa | Controls | p valuec |
|---|---|---|---|
| Age (years) | 49.05 ± 8.07529–71) | 51.00 ± 10.576 (24–65) | 0.386 |
| Male: female | 26:13 | 21:18 | 0.247 |
| El Escorial criteria (probable/definite) | 12/27 | – | – |
| Disease duration (months) | 17.77 ± 13.0012–71) | – | – |
| ALSFRS-Ra | 36.18 ± 6.472 (16–44) | – | – |
| Disease progression rateb | 0.9210 ± 0.70944 (0.17–3.14) | – | – |
a
ALS, amyotrophic lateral sclerosis; ALSFRS_R, ALS Functional Rating Scale_Revised.
b
Disease progression rate = (48–ALSFRS_R)/Disease duration.
c
Statistical significance was set at p < 0.05.